Nurix Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.18 M | $161.37 M | 100.00% | 9.87% |
| REDMILE GROUP, LLC | 11/14/2024 | 4.28 M | $96.19 M | -3.22% | 5.88% |
| VANGUARD GROUP INC | 11/13/2024 | 4.01 M | $90.15 M | 10.67% | 5.51% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 3.88 M | $87.23 M | 0.00% | 5.33% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 3.87 M | $86.92 M | -3.09% | 5.31% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 3.48 M | $78.24 M | 8.75% | 4.78% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.07 M | $68.96 M | 8.25% | 4.22% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 2.55 M | $57.26 M | 16.39% | 3.50% |
| STATE STREET CORP | 11/14/2024 | 2.37 M | $53.28 M | -12.45% | 3.26% |
| ARK INVESTMENT MANAGEMENT LLC | 10/31/2024 | 2.22 M | $49.80 M | -4.60% | 3.05% |
| MORGAN STANLEY | 11/14/2024 | 1.88 M | $42.21 M | -5.59% | 2.58% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.79 M | $40.19 M | 52.41% | 2.46% |
| COMMODORE CAPITAL LP | 11/14/2024 | 1.65 M | $37.08 M | 100.00% | 2.27% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.53 M | $34.41 M | 47.14% | 2.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.45 M | $32.54 M | 9.56% | 1.99% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.29 M | $28.89 M | 0.20% | 1.77% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 1.07 M | $23.95 M | -48.16% | 1.46% |
| CANDRIAM S.C.A. | 11/13/2024 | 1.06 M | $23.86 M | -8.79% | 1.46% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 860,399 | $19.33 M | -5.66% | 1.18% |
| WASATCH ADVISORS LP | 11/14/2024 | 708,377 | $15.92 M | -17.45% | 0.97% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 673,554 | $15.13 M | -31.35% | 0.93% |
| FMR LLC | 11/13/2024 | 586,902 | $13.19 M | 675.85% | 0.81% |
| SAMLYN CAPITAL, LLC | 11/14/2024 | 568,264 | $12.77 M | -2.61% | 0.78% |
| BOXER CAPITAL, LLC | 11/14/2024 | 563,067 | $12.65 M | 100.00% | 0.77% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 11/05/2024 | 553,251 | $12.43 M | 100.00% | 0.76% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/07/2024 | 552,602 | $12.41 M | 100.00% | 0.76% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 513,221 | $11.53 M | 10.49% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 511,720 | $11.50 M | -17.92% | 0.70% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 501,569 | $11.27 M | -16.84% | 0.69% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 438,971 | $9.86 M | -7.52% | 0.60% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 425,000 | $9.55 M | -15.00% | 0.58% |
| OPALEYE MANAGEMENT INC. | 11/14/2024 | 420,000 | $9.44 M | 0.26% | 0.58% |
| INVESCO LTD. | 11/12/2024 | 413,340 | $9.29 M | 13.15% | 0.57% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 355,602 | $7.99 M | -17.74% | 0.49% |
| LORD, ABBETT & CO. LLC | 12/13/2024 | 350,640 | $7.88 M | 100.00% | 0.48% |
| WOODLINE PARTNERS LP | 11/14/2024 | 336,879 | $7.57 M | 11.59% | 0.46% |
| PATIENT SQUARE CAPITAL LP | 11/14/2024 | 325,789 | $7.32 M | 100.00% | 0.45% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 314,762 | $7.07 M | 0.00% | 0.43% |
| BESSEMER GROUP INC | 11/12/2024 | 306,053 | $6.88 M | 0.02% | 0.42% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 300,000 | $6.74 M | 72.03% | 0.41% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 290,000 | $6.52 M | 0.00% | 0.40% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 260,000 | $5.84 M | -40.98% | 0.36% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 246,400 | $5.54 M | -23.95% | 0.34% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 241,048 | $5.42 M | -28.04% | 0.33% |
| WESTHILL FINANCIAL ADVISORS, INC. | 10/18/2024 | 238,333 | $5.36 M | -15.88% | 0.33% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 221,718 | $4.98 M | -63.02% | 0.30% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 214,728 | $4.82 M | 125.03% | 0.30% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 203,015 | $4.56 M | -0.13% | 0.28% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 200,000 | $4.49 M | 33.33% | 0.27% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 180,000 | $4.04 M | 404.99% | 0.25% |
Nurix Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 210 institutional investors and hedge funds held shares of Nurix Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 7.18 M
Redmile Group, LLC: 4.28 M
VANGUARD GROUP INC: 4.01 M
BAKER BROS. ADVISORS LP: 3.88 M
Deep Track Capital, LP: 3.87 M
WELLINGTON MANAGEMENT GROUP LLP: 3.48 M
92.84% of Nurix Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.36 M shares in the last 24 months. This purchase volume represents approximately $1.61 B in transactions.